GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

Home・Akcijų sąrašas・Orexo AB

O
Orexo AB

Uždarymo kaina

21.95 3.29

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

22.7

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-68M -116M
Pardavimai	-115M 3.3M
Pelnas, tenkantis vienai akcijai	20.884
Pelno marža	-3,503.03
Darbuotojai	72
EBITDA	-262M -272M

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-28

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-255M 779M
Ankstesnė atidarymo kaina	18.66
Ankstesnė uždarymo kaina	21.95

Orexo AB Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-24 18:58; UTC

Pagrindinės rinkos jėgos

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

2026-03-24 23:48; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-24 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

2026-03-24 23:33; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Rises, Boosted by Dollar Weakness -- Market Talk

2026-03-24 23:16; UTC

Rinkos pokalbiai

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

2026-03-24 21:44; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-24 21:44; UTC

Rinkos pokalbiai

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

2026-03-24 20:59; UTC

Uždarbis

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

2026-03-24 20:58; UTC

Svarbiausios naujienos

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

2026-03-24 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Energy & Utilities Roundup: Market Talk

2026-03-24 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-24 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-24 20:25; UTC

Uždarbis

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

2026-03-24 20:15; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Commodities Roundup: Market Talk

2026-03-24 20:10; UTC

Rinkos pokalbiai

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q Sales $378.7M >WOR

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q Adj EPS 98c >WOR

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q EPS 92c >WOR

2026-03-24 19:25; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

2026-03-24 19:06; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

2026-03-24 18:51; UTC

Rinkos pokalbiai

Svarbiausios naujienos

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

2026-03-24 18:40; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-03-24 18:40; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

2026-03-24 18:34; UTC

Svarbiausios naujienos

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

2026-03-24 18:27; UTC

Rinkos pokalbiai

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

2026-03-24 18:21; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Silver Snaps 9-Session Losing Streak -- Market Talk

2026-03-24 18:00; UTC

Įsigijimai, susijungimai, perėmimai

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Orexo AB Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.